Bicycle Therapeutics plc (BCYC) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 490.5M |
| Enterprise Value | -120.09M |
| P/E Ratio | -1.26 |
| PEG Ratio | 0.35 |
| Price/Sales Ratio | 4.35 |
| Price/Book Ratio | 0.5 |
| Enterprise/Revenue | -4.22 |
| Enterprise/EBITDA | 1.27 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -3.45 |
| Operating Margin | -3.82 |
| Return On Assets | -0.34 |
| Return On Equity | -0.36 |
| Revenue | 72.59M |
| Revenue/Share | 0.91 |
| Gross Profit | 72.59M |
| EBITDA | -212.18M |
| Net Income | -218.96M |
| Diluted EPS | -3.16 |
| Total Cash | 559.47M |
| Total Cash/Share | 8.03 |
| Total Debt | 15.34M |
| Total Debt/Equity | 0.03 |
| Current Ratio | 12.66 |
| Book Value Per Share | 7.95 |
| 52-Week Change | -44.95 |
| 52-Week High | 9.18 |
| 52-Week Low | 3.95 |
| Moving Average 50 Days | 4.6 |
| Moving Average 200 Days | 6.08 |
| Average Volume | 475,122 |
| Shares Outstanding | 69.39M |
| % Held by Institutions | 54.07 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |